CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface

B M Carreno1, F Bennett, T A Chau

  • 1Genetics Institute, Inc., Cambridge, MA 02140, USA.

Insights

Cytotoxic T-Lymphocyte-Associated protein 4 (CTLA-4) down-regulates T cell activation through two distinct mechanisms: a negative signal requiring its cytoplasmic region or B7 sequestration, depending on cell surface levels.

Area of Science:

  • Immunology
  • Cellular Biology
  • Molecular Biology

Background:

  • Cytotoxic T-Lymphocyte-Associated protein 4 (CTLA-4) is a key regulator of T cell activation.
  • Two primary mechanisms, negative signaling and competitive antagonism of CD28:B7 costimulation, have been proposed for CTLA-4's inhibitory function.

Purpose of the Study:

  • To elucidate the distinct contributions of CTLA-4's negative signaling and B7 sequestration mechanisms in T cell activation.
  • To investigate the role of the CTLA-4 cytoplasmic region in mediating these inhibitory functions.

Main Methods:

  • Utilized T cell lines engineered to express human CTLA-4 with mutations in its cytoplasmic region.
  • Assessed the impact of CTLA-4 engagement on IL-2 production under both B7-independent and B7-dependent costimulation conditions.

Main Results:

  • CTLA-4-mediated inhibition of IL-2 production under B7-independent costimulation required the CTLA-4 cytoplasmic region.
  • Under B7-dependent costimulation, CTLA-4's inhibition of IL-2 production was dependent on cell surface levels and did not require the cytoplasmic region.

Conclusions:

  • CTLA-4 employs dual mechanisms for T cell activation down-regulation: negative signaling and B7 sequestration.
  • The operational mechanism depends on CTLA-4 surface expression levels, potentially leading to rapid inhibition or T cell anergy.

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...